Source comparison
The Honest Truth About CJC-1295 vs Mod GRF Naming
Here's the honest answer: the peptide industry created this distinction to solve a supplier communication problem, not a molecular one. When DAC-modified CJC-1295 entered the research market in the mid-2000s, it was simply called 'CJC-1295.' Researchers who wa
This comparison does not assign a generated winner or score.
- Here's the honest answer: the peptide industry created this distinction to solve a supplier communication problem, not a molecular one. When DAC-modified CJC-1295 entered the research market in the mid-2000s, it was simply called 'CJC-1295.' Researchers who wanted the shorter-acting, unmodified version had no clear way to specify that. So suppliers started labeling it 'CJC-1295 No DAC' or 'CJC-1295 without DAC' as a workaround. Meanwhile, the academic literature and peptide synthesis labs used the technically accurate term 'Modified GRF 1-29' or 'Mod GRF (1-29)' to describe the same compound.
- The result: three names (CJC-1295 No DAC, Mod GRF 1-29, Sermorelin analog) all referring to the identical 29-amino-acid sequence, leading researchers to treat them as distinct compounds and construct elaborate comparison protocols that amount to testing batch-to-batch formulation variance, not peptide differences. We mean this sincerely: if you're debating which 'version' to use, you're asking the wrong question. The only meaningful choice is DAC vs No DAC. And that choice determines whether you're running a continuous-elevation protocol or a pulsatile-mimetic protocol. Everything else is supplier branding.